Cargando…

Vancomycin-induced bullous dermatosis: a rare case report

Linear IgA bullous dermatosis (LABD) is a rare acquired skin blistering autoimmune disease. It can be diagnosed by confirming the presence of a linear band of IgA at the dermoepidermal junction on direct immunofluorescence microscopy. LABD can be characterized by vesicular lesions, diffuse blisters,...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakkal, Najeeb, Jazmati, Aya, Alosman, Majd Aldeen, Alali, Kutaiba, Wereekia, Mahmoud, Kadi, Mohamad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289537/
https://www.ncbi.nlm.nih.gov/pubmed/37363561
http://dx.doi.org/10.1097/MS9.0000000000000752
_version_ 1785062301568598016
author Sakkal, Najeeb
Jazmati, Aya
Alosman, Majd Aldeen
Alali, Kutaiba
Wereekia, Mahmoud
Kadi, Mohamad
author_facet Sakkal, Najeeb
Jazmati, Aya
Alosman, Majd Aldeen
Alali, Kutaiba
Wereekia, Mahmoud
Kadi, Mohamad
author_sort Sakkal, Najeeb
collection PubMed
description Linear IgA bullous dermatosis (LABD) is a rare acquired skin blistering autoimmune disease. It can be diagnosed by confirming the presence of a linear band of IgA at the dermoepidermal junction on direct immunofluorescence microscopy. LABD can be characterized by vesicular lesions, diffuse blisters, or even as a mimicker of Steven–Johnson syndrome. LABD may be caused by tumours, infections, or drugs (amiodarone, furosemide, phenytoin, however, vancomycin is the potential inciting drug in most reports). CASE PRESENTATION: The authors present here a case of a 61-year-old woman with a history of HTN. The patient had a discectomy 15 years ago, and also underwent a lumbar fusion surgery that resulted in complications with her discitis. Due to the complications from the surgery, intravenous treatment with vancomycin and meropenem was initiated. After a few days of treatment, the patient developed clear, tense, fluid-filled bullae over the upper extremities. Immunofluorescence microscopy is not available in our hospital. Therefore a diagnosis of vancomycin-induced LABD was proposed based on the clinical manifestation of the lesions and the coincidence with vancomycin administration. After 2 days of discontinuing the administration of vancomycin and applying local diprosone, the lesions started to regress and a full recovery was achieved on day 10. DISCUSSION AND CONCLUSION: Even though drug-induced LABD is uncommon, its incidence has been steadily increasing in the last few years. LABD is a simple condition with a good prognosis and full recovery after the discontinuation of vancomycin
format Online
Article
Text
id pubmed-10289537
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-102895372023-06-24 Vancomycin-induced bullous dermatosis: a rare case report Sakkal, Najeeb Jazmati, Aya Alosman, Majd Aldeen Alali, Kutaiba Wereekia, Mahmoud Kadi, Mohamad Ann Med Surg (Lond) Case Reports Linear IgA bullous dermatosis (LABD) is a rare acquired skin blistering autoimmune disease. It can be diagnosed by confirming the presence of a linear band of IgA at the dermoepidermal junction on direct immunofluorescence microscopy. LABD can be characterized by vesicular lesions, diffuse blisters, or even as a mimicker of Steven–Johnson syndrome. LABD may be caused by tumours, infections, or drugs (amiodarone, furosemide, phenytoin, however, vancomycin is the potential inciting drug in most reports). CASE PRESENTATION: The authors present here a case of a 61-year-old woman with a history of HTN. The patient had a discectomy 15 years ago, and also underwent a lumbar fusion surgery that resulted in complications with her discitis. Due to the complications from the surgery, intravenous treatment with vancomycin and meropenem was initiated. After a few days of treatment, the patient developed clear, tense, fluid-filled bullae over the upper extremities. Immunofluorescence microscopy is not available in our hospital. Therefore a diagnosis of vancomycin-induced LABD was proposed based on the clinical manifestation of the lesions and the coincidence with vancomycin administration. After 2 days of discontinuing the administration of vancomycin and applying local diprosone, the lesions started to regress and a full recovery was achieved on day 10. DISCUSSION AND CONCLUSION: Even though drug-induced LABD is uncommon, its incidence has been steadily increasing in the last few years. LABD is a simple condition with a good prognosis and full recovery after the discontinuation of vancomycin Lippincott Williams & Wilkins 2023-05-08 /pmc/articles/PMC10289537/ /pubmed/37363561 http://dx.doi.org/10.1097/MS9.0000000000000752 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Case Reports
Sakkal, Najeeb
Jazmati, Aya
Alosman, Majd Aldeen
Alali, Kutaiba
Wereekia, Mahmoud
Kadi, Mohamad
Vancomycin-induced bullous dermatosis: a rare case report
title Vancomycin-induced bullous dermatosis: a rare case report
title_full Vancomycin-induced bullous dermatosis: a rare case report
title_fullStr Vancomycin-induced bullous dermatosis: a rare case report
title_full_unstemmed Vancomycin-induced bullous dermatosis: a rare case report
title_short Vancomycin-induced bullous dermatosis: a rare case report
title_sort vancomycin-induced bullous dermatosis: a rare case report
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289537/
https://www.ncbi.nlm.nih.gov/pubmed/37363561
http://dx.doi.org/10.1097/MS9.0000000000000752
work_keys_str_mv AT sakkalnajeeb vancomycininducedbullousdermatosisararecasereport
AT jazmatiaya vancomycininducedbullousdermatosisararecasereport
AT alosmanmajdaldeen vancomycininducedbullousdermatosisararecasereport
AT alalikutaiba vancomycininducedbullousdermatosisararecasereport
AT wereekiamahmoud vancomycininducedbullousdermatosisararecasereport
AT kadimohamad vancomycininducedbullousdermatosisararecasereport